Cargando…

Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis

Symptomatic intracerebral hemorrhage (sICH) occurs in up to 7% of stroke patients treated with thrombolytic therapy. There are limited data on the effectiveness of the reversal agents used for intravenous tissue plasminogen activator related intracranial bleeds. We report a patient with sICH followi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaghi, Shadi, Haggiagi, Aya, Sherzai, Ayesha, Marshall, Randolph S., Agarwal, Sachin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500881/ https://www.ncbi.nlm.nih.gov/pubmed/26236459 http://dx.doi.org/10.4081/cp.2015.756

Ejemplares similares

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Ventricular Extension of Intracerebral Hemorrhage during Intravenous Thrombolysis
por: Harston, George W.J., et al.
Publicado: (2013)

Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: Lin, Ting-Chun, et al.
Publicado: (2018)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Machine learning-based prediction of symptomatic intracerebral hemorrhage after intravenous thrombolysis for stroke: a large multicenter study
por: Wen, Rui, et al.
Publicado: (2023)

Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Cerebral Microbleeds and Cardiac Myxoma
por: Chutinet, Aurauma, et al.
Publicado: (2014)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Oxfordshire community stroke project classification improves prediction of post-thrombolysis symptomatic intracerebral hemorrhage
por: Sung, Sheng-Feng, et al.
Publicado: (2014)

Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis
por: Choi, Jay Chol, et al.
Publicado: (2016)

Circulating Inflammatory Biomarkers Level before Thrombolysis for Acute Ischemic Stroke Predicts Symptomatic Intracerebral Hemorrhage
por: Li, Lingzhi, et al.
Publicado: (2023)

Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas
por: Koh, Young Rae, et al.
Publicado: (2012)

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
por: Chou, S, et al.
Publicado: (2011)

A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients
por: Guo, Hongquan, et al.
Publicado: (2021)

Predictors of Postthrombolysis Outcome and Symptomatic Postthrombolysis Hemorrhage following Intravenous Thrombolysis with Alteplase for Acute Ischemic Stroke
por: Das, Suman, et al.
Publicado: (2020)

Personalized risk prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis using a machine-learning model
por: Wang, Feng, et al.
Publicado: (2020)

Recombinant Factor VIIa in Post-partum Hemorrhage: A New Weapon in Obstetrician's Armamentarium
por: Magon, Navneet, et al.
Publicado: (2012)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis
por: Tanaka, Koji, et al.
Publicado: (2019)

Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage
por: Staub-Bartelt, Franziska, et al.
Publicado: (2020)

A Novel Nomogram to Predict Symptomatic Intracranial Hemorrhage in Ischemic Stroke Patients After Intravenous Thrombolysis
por: Jiang, Zhuangzhuang, et al.
Publicado: (2023)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Thrombolysis-Related Intracerebral Hemorrhage and Cerebral Amyloid Angiopathy: Accumulating Evidence
por: Charidimou, Andreas, et al.
Publicado: (2015)

Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis
por: Kongbunkiat, Kannikar, et al.
Publicado: (2017)

Simple Estimates of Symptomatic Intracranial Hemorrhage Risk and Outcome after Intravenous Thrombolysis Using Age and Stroke Severity
por: Lee, Hye Jung, et al.
Publicado: (2017)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Machine learning prediction of symptomatic intracerebral hemorrhage after stroke thrombolysis: a cross-cultural validation in Caucasian and Han Chinese cohort
por: Liu, Junfeng, et al.
Publicado: (2022)

Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study
por: H-Y, Chou Sherry, et al.
Publicado: (2012)

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals
por: Diaz, Raiko, et al.
Publicado: (2019)

Frequency and predictors of symptomatic intracranial hemorrhage after intravenous thrombolysis for acute ischemic stroke in a Brazilian public hospital
por: Cougo-Pinto, Pedro Telles, et al.
Publicado: (2012)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Delayed symptomatic intracerebral hemorrhages in neuro-Behcet’s disease
por: Lee, Woo-Jin, et al.
Publicado: (2016)

Risk factors for intracerebral hemorrhage in patients with COVID-19
por: Melmed, Kara R., et al.
Publicado: (2020)

Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study
por: Lin, Sheng-Feng, et al.
Publicado: (2019)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ratrtasl2m6i352bj0mm01akm6